Last reviewed 2026-06-02 · How we verify

Amoxicillin healing phase

Belén Retamal-Valdes · Phase 1 active Small molecule Under review

Amoxicillin healing phase is a Beta-lactam antibiotic Small molecule drug developed by Belén Retamal-Valdes. It is currently in Phase 1 development for Bacterial infections. Also known as: AMX 2.

Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.

Amoxicillin, a small molecule antibiotic, is used to treat conditions such as peri-implantitis, partially edentulous jaw, and chronic periodontitis. It is administered systemically as part of a treatment plan that may include surgical interventions like open flap debridement and Er: YAG irradiation.

Likelihood of approval

11.6% vs 9.6% industry baseline

If approved by FDA: likely 2033–2036

Steps remaining: Phase 2 → Phase 3 → NDA/BLA submission

Confidence: Medium

Why this estimate

Baseline phase 1 → approval rate +9.6pp
Industry-wide phase 1 drugs reach approval ~9.6% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
Anti-infectives pathway favourability +2.0pp
Microbiological endpoints + non-inferiority designs raise approval rates above baseline.

Predicted approval windows by jurisdiction (conditional on FDA approval)

Regulator	Country	Likely year	Lag vs FDA
FDA	US	2033–2036	—
EMA	EU	2034–2037	+0.7 yr
MHRA	GB	2034–2037	+0.7 yr
Health Canada	CA	2034–2038	+0.9 yr
TGA	AU	2034–2038	+1.2 yr
PMDA	JP	2034–2038	+1.5 yr
NMPA	CN	2035–2039	+2.3 yr
MFDS	KR	2034–2038	+1.4 yr
CDSCO	IN	2034–2039	+1.8 yr
ANVISA	BR	2035–2039	+2.3 yr

Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).

Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.

At a glance

Generic name	Amoxicillin healing phase
Also known as	AMX 2
Sponsor	Belén Retamal-Valdes
Drug class	Beta-lactam antibiotic
Target	Penicillin-binding proteins
Modality	Small molecule
Therapeutic area	Infectious Disease
Phase	Phase 1

Mechanism of action

This action results in the disruption of the bacterial cell wall, ultimately leading to cell lysis and death.

Approved indications

Bacterial infections

Common side effects

Diarrhea
Nausea
Vomiting

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Amoxicillin healing phase CI brief — competitive landscape report
Amoxicillin healing phase updates RSS · CI watch RSS
Belén Retamal-Valdes portfolio CI

Frequently asked questions about Amoxicillin healing phase

What is Amoxicillin healing phase?

Amoxicillin healing phase is a Beta-lactam antibiotic drug developed by Belén Retamal-Valdes, indicated for Bacterial infections.

How does Amoxicillin healing phase work?

Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.

What is Amoxicillin healing phase used for?

Amoxicillin healing phase is indicated for Bacterial infections.

Who makes Amoxicillin healing phase?

Amoxicillin healing phase is developed by Belén Retamal-Valdes (see full Belén Retamal-Valdes pipeline at /company/bel-n-retamal-valdes).

Is Amoxicillin healing phase also known as anything else?

Amoxicillin healing phase is also known as AMX 2.

What drug class is Amoxicillin healing phase in?

Amoxicillin healing phase belongs to the Beta-lactam antibiotic class. See all Beta-lactam antibiotic drugs at /class/beta-lactam-antibiotic.

What development phase is Amoxicillin healing phase in?

Amoxicillin healing phase is in Phase 1.

What are the side effects of Amoxicillin healing phase?

Common side effects of Amoxicillin healing phase include Diarrhea, Nausea, Vomiting.

What does Amoxicillin healing phase target?

Amoxicillin healing phase targets Penicillin-binding proteins and is a Beta-lactam antibiotic.

Drug class: All Beta-lactam antibiotic drugs
Target: All drugs targeting Penicillin-binding proteins
Manufacturer: Belén Retamal-Valdes — full pipeline
Therapeutic area: All drugs in Infectious Disease
Indication: Drugs for Bacterial infections
Also known as: AMX 2

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing